This company has been marked as potentially delisted and may not be actively trading. Range Cancer Therapeutics ETF Rating Add Compare Share Share Ratings Stock AnalysisHoldingsRatingsShort InterestTrendsBuy This Stock Range Cancer Therapeutics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CNCR Aggregate RatingModerate Buy 2.81Holdings in CNCR have an aggregate rating of Moderate Buy based on 510 analyst ratings issued in the past year covering 50 companies (79.5% of the portfolio).CNCR Aggregate Price Target$9.74-0.05% DownsideHigh Prediction$9.74Average Prediction$9.74Low Prediction$9.74Holdings in CNCR have an aggregate price target of $9.74 and a range of $9.74 to $9.74 covering 50 companies (79.5% of the portfolio).CNCR Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy22 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Range Cancer Therapeutics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 CNCR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.84%IBRXImmunityBio$2.59-3.6%1.8944 of 5 stars3.00$12.19 370.2%5Analyst Forecast1.84%HCMHUTCHMED$14.61-7.2%2.066 of 5 stars2.00$19.00 30.1%1News CoverageGap Up1.82%RAPTRAPT Therapeutics$0.88+0.6%3.6358 of 5 stars2.11$4.00 354.5%9Positive NewsGap Down1.78%SMMTSummit Therapeutics$23.29-36.5%2.624 of 5 stars3.00$36.70 57.6%10Upcoming EarningsAnalyst ForecastGap DownTrading HaltedHigh Trading Volume1.77%YMABY-mAbs Therapeutics$4.09-1.1%3.5978 of 5 stars2.82$17.40 325.9%11Analyst DowngradeAnalyst RevisionNews Coverage1.77%INBXInhibrx$12.27+2.4%1.9516 of 5 stars2.001Positive News1.76%EXELExelixis$37.40+0.5%4.2988 of 5 stars2.50$37.59 0.5%20Upcoming EarningsPositive News1.76%TSVT2seventy bio$4.99-0.1%2.2607 of 5 stars2.29$5.60 12.3%7Upcoming EarningsAnalyst Forecast1.75%SNDXSyndax Pharmaceuticals$13.36+0.4%3.4597 of 5 stars2.90$36.20 171.1%10Positive News1.74%BMYBristol-Myers Squibb$47.75-1.9%4.7677 of 5 stars2.33$58.00 21.5%21Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionNews Coverage1.72%LYELLyell Immunopharma$0.44-5.4%3.1762 of 5 stars1.50$1.00 126.2%21.72%IMCRImmunocore$30.09-0.9%2.5951 of 5 stars2.54$60.90 102.4%13News CoveragePositive News1.71%BPMCBlueprint Medicines$87.53+1.7%2.6303 of 5 stars2.70$124.95 42.8%23Upcoming EarningsNews Coverage1.66%IOVAIovance Biotherapeutics$3.50+4.0%4.2135 of 5 stars2.89$18.22 421.4%91.66%ELVNEnliven Therapeutics$18.13-0.9%2.1803 of 5 stars3.25$40.33 122.4%41.66%ZYMEZymeworks$12.55+0.2%2.7233 of 5 stars2.88$21.00 67.3%8Positive News1.64%SWTXSpringWorks Therapeutics$44.67-0.6%2.1876 of 5 stars3.00$73.20 63.9%5Upcoming EarningsNews CoverageHigh Trading Volume1.62%REGNRegeneron Pharmaceuticals$602.44+0.4%4.7916 of 5 stars2.88$945.32 56.9%26Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive News1.62%BNTXBioNTech$101.78-15.6%2.4903 of 5 stars2.89$143.44 40.9%18Analyst RevisionHigh Trading Volume1.62%ACLXArcellx$63.71-0.4%2.0529 of 5 stars3.14$110.67 73.7%14News CoveragePositive NewsGap Down1.61%NUVLNuvalent$73.01-1.3%1.8362 of 5 stars2.90$115.50 58.2%10News CoveragePositive News1.61%DAWNDay One Biopharmaceuticals$7.74-2.0%2.4101 of 5 stars3.13$32.29 317.2%8Analyst Revision1.60%MRKMerck & Co., Inc.$82.72+3.6%5 of 5 stars2.59$111.13 34.3%22Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionPositive News1.60%MRUSMerus$43.57-1.8%3.1473 of 5 stars3.13$85.31 95.8%16Positive News1.60%GERNGeron$1.42-0.4%3.8022 of 5 stars2.82$5.75 306.4%11Analyst RevisionGap Down1.59%GMABGenmab A/S$20.59+0.2%4.2285 of 5 stars2.69$39.17 90.3%13Analyst Revision1.57%KURAKura Oncology$6.42-0.2%4.3063 of 5 stars2.92$25.50 297.5%12Upcoming EarningsPositive NewsGap Down1.57%JANXJanux Therapeutics$30.95-3.5%2.663 of 5 stars3.09$95.25 207.8%11Insider TradePositive News1.55%RVMDRevolution Medicines$38.76+0.5%3.8816 of 5 stars3.00$66.67 72.0%12Positive News1.55%IPHAInnate Pharma$2.01-0.2%2.0737 of 5 stars3.50$11.00 448.6%2Analyst ForecastAnalyst RevisionNews CoverageGap Up1.54%LEGNLegend Biotech$34.25+0.0%2.2037 of 5 stars2.92$78.82 130.1%12Analyst ForecastPositive NewsGap Up1.52%CGEMCullinan Therapeutics$8.09-0.6%2.2693 of 5 stars3.00$34.80 330.1%6News CoveragePositive News1.51%ERASErasca$1.39-1.1%3.1416 of 5 stars3.00$4.83 249.0%6News CoveragePositive NewsGap Down1.51%AUTLAutolus Therapeutics$1.32-6.1%2.4086 of 5 stars3.00$9.32 608.7%6Analyst RevisionNews Coverage1.51%RCUSArcus Biosciences$8.24-2.1%2.1309 of 5 stars3.00$28.38 244.5%10Analyst ForecastGap Down1.50%NUVBNuvation Bio$2.13-0.2%3.1719 of 5 stars3.17$7.83 268.6%6Analyst Forecast1.50%IDYAIDEAYA Biosciences$18.98-0.5%3.6134 of 5 stars2.93$53.58 182.4%15Positive NewsGap Up1.50%BMEABiomea Fusion$2.18-5.4%2.5449 of 5 stars3.00$23.91 999.3%13Upcoming Earnings1.48%CRBUCaribou Biosciences$0.77-11.3%2.3933 of 5 stars3.00$10.33 1,235.1%5News Coverage1.47%SDGRSchrödinger$26.39+1.0%2.379 of 5 stars3.00$33.00 25.0%8Upcoming Earnings1.47%IMTXImmatics$4.55-2.7%2.6022 of 5 stars3.20$16.67 266.7%51.46%PGENPrecigen$1.51-4.8%3.0571 of 5 stars3.00$7.00 362.4%41.45%ARVNArvinas$9.05-1.0%3.2979 of 5 stars2.69$34.33 279.6%161.43%NRIXNurix Therapeutics$11.53+0.1%2.3783 of 5 stars2.84$30.44 164.0%19Positive News1.42%BCYCBicycle Therapeutics$8.36-2.8%1.9149 of 5 stars2.75$29.14 248.6%8Upcoming EarningsNews Coverage1.41%TYRATyra Biosciences$10.05-0.4%2.0561 of 5 stars3.00$30.83 206.7%6Positive News1.40%FATEFate Therapeutics$1.28-5.6%3.6697 of 5 stars2.22$5.43 325.8%9Gap Up1.38%ITOSiTeos Therapeutics$7.36-1.4%2.2598 of 5 stars3.00$25.75 250.1%4Positive News1.38%AURAAura Biosciences$5.38-2.5%2.3075 of 5 stars3.25$22.75 322.8%8Positive News1.37%ALLOAllogene Therapeutics$1.55-1.6%3.0012 of 5 stars2.90$9.29 501.2%10News CoverageGap Down This page (NASDAQ:CNCR) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Range Cancer Therapeutics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNCR Stock Free CNCR Stock Alerts